Nucleic Acids Research, 1990, Vol. 18, No. 13 3697-3703
© 1990
GENOME STRUCTURE AND MAPPING |
The human interleukin-2 receptor ß-chain gene: genomic organization, promoter analysis and chromosomal assignment
Institute for Molecular and Cellular Biology, Osaka University 1-3 Yamadaoka, Suita-shi, Osaka 565, Japan 1Howard Hughes Medical Institute, Research Laboratories, University of Utah 701 Wintrobe Building, Room 631, Salt Lake City, UT 84132, USA
*To whom correspondence should be addressed
Received May 18, 1990. Accepted June 6, 1990.
The chromosomal gene for the human interleukin-2 receptor ß-chain (IL-2Rß) was isolated and characterized. The entire IL-2Rß3 gene is composed of ten exons spanning about 24.3 kilobases, in which the protein is encoded by the exons 210. The cysteine rich extracellular region which displays a significant evolutionary resemblance to other cytokine receptors, as well as growth hormone and prolactin receptors, is encoded primarily by exons 3 and 4, whereas the membrane proximal, cysteine poor domain showing a homology with type III modules of fibronectin is encoded by exon 7. Sequence analysis of the 5'-flanking region revealed the presence of potential binding sites for transcription factors such as Octamer binding factors, AP-1, AP-2 as well as the GC-clusters. At least five potential cap sites were identified by S1 mapping analysis. The 850 bp DNA sequence of the 5'-flanking region exhibited constitutive promoter activity when it was linked upstream of the HSV-tk reporter gene and then transfected into YT cells, a human leukemic cell line. By applying the RFLP linkage analysis, the IL-2Rß gene has been assigned to chromosome 22q1213.
+Present address: Department of Biochemistry. Cancer Institute Japanese Foundation for Cancer Research, Toshima-ku, Tokyo 170, Japan
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. F. Zheng, G. J. Jones, M. Shi, J. C. D. Wiseman, K. J. Marr, B. M. Berenger, S. M. Huston, M. J. Gill, A. M. Krensky, P. Kubes, et al. Late Expression of Granulysin by Microbicidal CD4+ T Cells Requires PI3K- and STAT5-Dependent Expression of IL-2R{beta} That Is Defective in HIV-Infected Patients J. Immunol., June 1, 2008; 180(11): 7221 - 7229. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.C. Church Clinical advances in therapies targeting the interleukin-2 receptor QJM, February 1, 2003; 96(2): 91 - 102. [Full Text] [PDF] |
||||
![]() |
G. Gorgun and F. Foss Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox Blood, July 30, 2002; 100(4): 1399 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Tucker, H. K. Jessup, H. Fujii, and C. B. Wilson Enforced expression of the Ikaros isoform IK5 decreases the numbers of extrathymic intraepithelial lymphocytes and natural killer 1.1+ T cells Blood, January 15, 2002; 99(2): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Suzuki, T. Kundig, C Furlonger, A Wakeham, E Timms, T Matsuyama, R Schmits, J. Simard, P. Ohashi, H Griesser, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta Science, June 9, 1995; 268(5216): 1472 - 1476. [Abstract] [PDF] |
||||
![]() |
K. Ohbo, N. Takasawa, N. Ishii, N. Tanaka, M. Nakamura, and K. Sugamura Functional Analysis of the Human Interleukin 2 Receptor [IMAGE] Chain Gene Promoter J. Biol. Chem., March 31, 1995; 270(13): 7479 - 7486. [Abstract] [Full Text] [PDF] |
||||




